In contrast, it has been hypothesised that, due to potent activities in allergy and responses to parasites, IgE antibodies may be directed against cancers by recruiting and activating aspects of patient immunity and the tumour microenvironment not normally accessed by IgG class antibodies. This evidence concerns the gene IGHE and neoplasm.